Spastic perineum syndrome
Also known as: Disorder, Syndrome, Diseases, Condition
Methodology & AI Transparency ⓘ
Spastic perineum syndrome Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Physicians managing Spastic perineum syndrome (also termed Disorder or Syndrome) (N81.89; PCOS, Endometriosis & Gynecologic Health) utilize metabolic/thyroid/prolactin hormone panels [Spastic perineum syndrome N81.89] and objective Free & Total in Spastic perineum syndrome (N81.89: Testosterone + SHBG) targets (Sex-specific physiological range (N81.89)) to prevent progression and functional morbidity.
- 2 Real-world patient consensus: Synonyms for Spastic perineum syndrome (N81.89): Disorder, Syndrome, Diseases (OB/GYN & PCOS).
- 3 Typical cash cost range: Primary evaluation for Spastic perineum syndrome incorporates metabolic/thyroid/prolactin hormone panels [Spastic perineum syndrome N81.89] and symptom diary review.
- 4 Top reported side effects / signs: Longitudinal Spastic perineum syndrome monitoring tracks Free & Total in Spastic perineum syndrome (N81.89: Testosterone + SHBG) toward Sex-specific physiological range (N81.89).
Ask our AI Specialists anything about Spastic perineum syndrome
What Is Spastic perineum syndrome?
Physicians managing Spastic perineum syndrome (also termed Disorder or Syndrome) (N81.89; PCOS, Endometriosis & Gynecologic Health) utilize metabolic/thyroid/prolactin hormone panels [Spastic perineum syndrome N81.89] and objective Free & Total in Spastic perineum syndrome (N81.89: Testosterone + SHBG) targets (Sex-specific physiological range (N81.89)) to prevent progression and functional morbidity.
Pathophysiology, Underlying Causes & Clinical Presentation
Mechanistic hallmarks of Spastic perineum syndrome (N81.89) center on reduced hepatic SHBG in Spastic perineum syndrome (N81.89: (in PCOS)). targeted ob/gyn & pcos interventions aim to normalize Free & Total in Spastic perineum syndrome (N81.89: Testosterone + SHBG).
Common Symptoms & Clinical Signs
- • Presentation of Spastic perineum syndrome (N81.89): irregular, infrequent, or in Spastic perineum syndrome (N81.89: absent ovulatory menstrual)
- • Secondary Spastic perineum syndrome clinical sign: severe pelvic cramping [Spastic perineum syndrome N81.89]
- • Symptom flares in Spastic perineum syndrome correlating with Free & Total in Spastic perineum syndrome (N81.89: Testosterone + SHBG) deviation outside Sex-specific physiological range (N81.89)
- • Functional ob/gyn & pcos impact requiring metabolic/thyroid/prolactin hormone panels [Spastic perineum syndrome N81.89] evaluation (N81.89)
Spastic perineum syndrome Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | N81.89 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | PCOS, Endometriosis & Gynecologic Health | NLM Clinical Tables |
| Diagnostic / Lab Marker: Free & Total in Spastic perineum syndrome (N81.89: Testosterone + SHBG) | Sex-specific physiological range (N81.89) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Fasting Insulin & in Spastic perineum syndrome (N81.89: HbA1c) | Fasting insulin < 8 uIU/mL (N81.89) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: CBC & Serum in Spastic perineum syndrome (N81.89: Ferritin (heavy bleeding)) | Ferritin > 50 ng/mL (N81.89) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Spastic perineum syndrome
Treatment selection for Spastic perineum syndrome depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Spastic perineum syndrome)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on IncobotulinumtoxinA Efficacy/Safety in Upper-Limb Spasticity in children Cerebral: What a 350-Participant Study Found Data provide evidence for sustained real-world benefits and safety of multipattern incobotulinumtoxinA treatment in children and adolescents with upper-limb spasticity. Pediatric neurology • 2021-10-15 • Phase III Randomized Trial | N = 350 | 93/100 | PMID 34339951 ↗ |
| New Insights on Benefits and safety of onabotulinumtoxinA with standardized physiotherapy for the: What a 381-Participant Study Found OnabotulinumtoxinA was well tolerated and effective in reducing lower limb spasticity and improving functional outcomes versus placebo in children. NeuroRehabilitation • 2022-01-15 • Phase III Randomized Trial | N = 381 | 93/100 | PMID 34957954 ↗ |
| Can This Approach Help? Inside the Latest Research on IncobotulinumtoxinA for the treatment of lower-limb spasticity in children and Children/adolescents with lower-limb spasticity experienced multipattern benefits from incobotulinumtoxinA, which was safe and well-tolerated in doses up to 16 U/kg, maximum 400 U. Journal of pediatric rehabilitation medicine • 2021-01-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 34092664 ↗ |
| Can This Approach Help? Inside the Latest Research on Letrozole co-treatment during ovarian stimulation with gonadotrophins for IVF: a The remaining authors have no competing interests. Human reproduction (Oxford, England) • 2022-01-28 • Randomized Controlled Trial | N = 67 | 88/100 | PMID 34792133 ↗ |
| Can This Approach Help? Inside the Latest Research on Effect of Repeated abobotulinumtoxinA (Dysport®) Injections on Walking Velocity Clinically meaningful and statistically significant improvements in WV, step length, and cadence under all four test conditions were observed in patients with spastic hemiparesis after each aboBoNT-A treatment cycle. PM & R : the journal of injury, function, and rehabilitation • 2021-05-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 32741133 ↗ |
Spastic perineum syndrome Patient Community & “People Like Me” Threads
Filter Spastic perineum syndrome community threads and patient logs by age, biological sex, dosage, and treatment duration.